The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Lymphocytic Hypophysitis

Autoimmune Inflammation of the Pituitary Gland with Anterior or Panhypopituitarism

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Endokrinoloji department. Book Appointment →

What is Lymphocytic Hypophysitis?

Lymphocytic hypophysitis is an autoimmune inflammatory disease of the pituitary gland with annual incidence approximately 1 per 9 million.

Three main subtypes: lymphocytic adenohypophysitis (anterior pituitary, classically peripartum women), lymphocytic infundibuloneurohypophysitis (posterior pituitary and stalk, with diabetes insipidus), and lymphocytic panhypophysitis (both lobes affected).

Pathologically characterized by diffuse infiltration of lymphocytes, plasma cells, and macrophages with eventual fibrosis and atrophy of pituitary parenchyma.

Increasingly recognized as drug-induced form related to immune checkpoint inhibitors (ipilimumab, nivolumab, pembrolizumab) used in cancer immunotherapy, with distinct features and management.

Symptoms

Headache (50–70%) often retro-orbital or frontal from sellar mass effect
Visual disturbance: bitemporal hemianopia or visual field defects from optic chiasm compression (30–50%)
Anterior pituitary insufficiency: ACTH (most common, 60–80%), TSH, gonadotropin, growth hormone, prolactin deficiency in varying combinations
Diabetes insipidus from posterior pituitary or stalk involvement (20–40%, more common in panhypophysitis variant)
Hyperprolactinemia from stalk effect with galactorrhea, amenorrhea, infertility (10–20%)
Postpartum failure to lactate or persistent amenorrhea suggestive of Sheehan-like presentation
Symptoms of secondary adrenal insufficiency: fatigue, hypotension, hyponatremia, hypoglycemia

Risk Factors

Women in late pregnancy or postpartum period (classic presentation, female-to-male ratio 6:1 to 9:1)
Adults aged 30–50 years
Autoimmune disease association: thyroid disorders (Hashimoto, Graves), type 1 diabetes, primary adrenal insufficiency, IgG4-related disease, autoimmune polyglandular syndromes
Drug-induced: immune checkpoint inhibitors (especially anti-CTLA-4 ipilimumab, 10–17%), interferon-alpha, ribavirin
Infiltrative diseases for differential: granulomatous hypophysitis (sarcoidosis, tuberculosis, syphilis), IgG4-related hypophysitis, xanthomatous hypophysitis, Langerhans cell histiocytosis

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Pregnant or postpartum woman with new-onset headache, visual symptoms, or pituitary insufficiency
  • Sellar mass on imaging with atypical features (stalk thickening, peripheral enhancement, normal-to-small adenohypophysis) suggesting hypophysitis rather than adenoma
  • Patients on immune checkpoint inhibitors with fatigue, headache, or hypotension warranting hypophysitis workup
  • Known hypophysitis with treatment failure, recurrence, or progressive hormone deficiencies
  • Acute adrenal crisis or severe hyponatremia in patient with sellar mass

Treatment Methods

01
Comprehensive endocrine evaluation: morning cortisol and ACTH (or stimulation test), free T4 and TSH, LH, FSH, estradiol or testosterone, prolactin, IGF-1, electrolytes, glucose; water deprivation test if diabetes insipidus suspected
02
Pituitary MRI with contrast: characteristic homogeneous enhancement, enlarged pituitary with stalk thickening, loss of posterior pituitary 'bright spot' in posterior involvement, often without focal adenoma
03
Differentiation from pituitary adenoma: hypophysitis suggested by symmetric enlargement, stalk thickening, intact dural surface, peripheral rim enhancement, and clinical context (peripartum, autoimmune disease, immunotherapy)
04
Hormone replacement: hydrocortisone 15–25 mg/day for ACTH deficiency, levothyroxine for TSH deficiency, sex hormones as appropriate, desmopressin for diabetes insipidus
05
Glucocorticoid therapy for active inflammation: prednisolone 0.5–1 mg/kg/day for 4–8 weeks with gradual taper; reduces mass effect and may improve hormone function in some cases
06
Immunosuppression for relapsing or refractory cases: azathioprine, methotrexate, mycophenolate mofetil, rituximab in selected patients
07
Surgical decompression: transsphenoidal biopsy or partial resection for compressive symptoms, diagnostic uncertainty (especially distinguishing from adenoma or other infiltrative diseases), or progressive disease despite medical therapy
08
Immune checkpoint inhibitor-induced hypophysitis: high-dose glucocorticoids only if severe symptoms; hormone replacement is mainstay; permanent ACTH deficiency in majority despite treatment
09
Long-term follow-up: serial pituitary MRI every 6–12 months, periodic hormone testing, gradual taper of glucocorticoids, monitoring for autoimmune comorbidities; spontaneous remission occurs in some cases

Which Department to Visit?

You can visit our Endokrinoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Endokrinoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.